Exploring the Future of Rare Bleeding Disorder Treatment at EHC 2026
European Haemophilia Consortium (EHC) shared a post on LinkedIn:
“Reminder to EHC National Member Organisations (NMOs): registration for the EHC New Technologies Conference 2026 is still open!
Joining us in Bucharest, Romania, from 30 October to 1 November 2026, this conference will bring together EHC NMOs and healthcare professionals for an in-depth look at the latest medical advancements in rare bleeding disorders, including the new technologies set to reach the European market in the coming years.
Places are limited to two representatives per NMO on a first-come, first-served basis.
EHC will cover registration, travel (economy fare), and accommodation costs for participants nominated by NMOs.
The registration link has been sent directly to NMOs by email.
Haven’t registered yet?
Act now — spots are filling up!
Full event details.”
Stay updated with Hemostasis Today.
-
Aug 9, 2026, 02:08Shivam Bansal: Targeting Chemotherapy-Induced Thrombocytopenia in Children with Romiplostim
-
Aug 9, 2026, 01:48Paolo Zamboni: Treating Post-Thrombotic Syndrome by Eliminating Venous Reflux
-
Aug 8, 2026, 20:37Tammuella Chrisentery-Singleton: What Comes Next for Hemophilia Care With Non-Factor Therapies?
-
Aug 8, 2026, 20:36Michelle Cha: The Evolving Role of Nurse Coordinators in Hemophilia Gene Therapy
-
Aug 8, 2026, 20:35Benjamin Schumacher: The Future of Holistic Haemophilia A Care
-
Aug 8, 2026, 20:33Delilah F.: March Is Blood Clot Awareness Month
-
Aug 8, 2026, 20:31Jackie Maybin: Top 10 Research Priorities for Problematic Menstrual Bleeding in the UK
-
Aug 8, 2026, 17:02Mohammed Murad Hossain: Highlights from the 2nd Haematology and HSCT Workshop in Dhaka
-
Aug 8, 2026, 16:57Mohammed Al Kanan: Advancing Therapeutic Drug Monitoring in Pediatric Aplastic Anemia